Skip to Content

SINGULAIR

In the US, SINGULAIR (montelukast systemic) is a member of the drug class leukotriene modifiers and is used to treat Allergic Rhinitis, Asthma, Asthma - Maintenance and Bronchospasm Prophylaxis.

US matches:

UK matches:

Ingredient matches for SINGULAIR

Montelukast

Montelukast is reported as an ingredient of SINGULAIR in the following countries:

  • Egypt
  • Georgia
  • India
  • Peru
  • Tunisia
  • Turkey

Montelukast sodium (a derivative of Montelukast) is reported as an ingredient of SINGULAIR in the following countries:

  • Argentina
  • Australia
  • Austria
  • Belgium
  • Bosnia & Herzegowina
  • Brazil
  • Bulgaria
  • Canada
  • Chile
  • China
  • Colombia
  • Costa Rica
  • Croatia (Hrvatska)
  • Czech Republic
  • Denmark
  • Dominican Republic
  • El Salvador
  • Finland
  • France
  • Germany
  • Greece
  • Guatemala
  • Honduras
  • Hong Kong
  • Hungary
  • Iceland
  • Ireland
  • Israel
  • Italy
  • Japan
  • Latvia
  • Lithuania
  • Malaysia
  • Malta
  • Mexico
  • Netherlands
  • New Zealand
  • Nicaragua
  • Norway
  • Panama
  • Philippines
  • Poland
  • Portugal
  • Romania
  • Russian Federation
  • Serbia
  • Slovakia
  • South Africa
  • Spain
  • Sweden
  • Switzerland
  • Taiwan
  • Thailand
  • United Kingdom
  • United States
  • Vietnam

International Drug Name Search

Important Notice: The Drugs.com international database is in BETA release. This means it is still under development and may contain inaccuracies. It is not intended as a substitute for the expertise and judgement of your physician, pharmacist or other healthcare professional. It should not be construed to indicate that the use of any medication in any country is safe, appropriate or effective for you. Consult with your healthcare professional before taking any medication.

Hide